CAS 2209871-83-8

ETX0282

CAS: 2209871-83-8

ETX0282 is a covalent complex that contains an isopropyl group and a cyclic peptide. It is used to target enzymes in multidrug-resistant bacteria, such as enterobacterales, which are responsible for the development of infectious diseases. ETX0282 has been shown to be effective against gram-negative bacterial species, including Enterobacter strains. This drug has been shown to be safe for clinical use in humans and has completed phase I clinical trials. ETX0282 is an oral prodrug that is hydrolyzed by esterases or glucuronidases to release the active form, cefpodoxime proxetil. This drug targets enzymes involved in bacterial processes that are essential for cell wall biosynthesis, inhibiting protein synthesis and cell division.

Formula: C₁₃H₁₈FN₃O₈

Purity: Min. 95%

Molecular weight: 315.3 g/mol

Ref: 3D-FE178951

ETX0282

CAS: 2209871-83-8

ETX0282, oral class A/C β-lactamase inhibitor, developed by Entasis with cefpodoxime for bacterial infections.

Formula: C₁₃H₁₈FN₃O₅

Color and Shape: Solid

Molecular weight: 315.30

Ref: TM-T69797